Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 12, 2016
Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical TrialsW Joseph Herring, Kathleen M Connor, Ellen Snyder, et al.Headache|January 7, 2012
Randomized, controlled study of telcagepant in patients with migraine and coronary artery diseaseTony W Ho, Andrew P Ho, Bernard R Chaitman, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 22, 2017
Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical TrialsW Joseph Herring, Kathryn M Connor, Ellen Snyder, et al.Headache|October 20, 2012
Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineursDavid J Hewitt, Eric Pearlman, Mirja Hämäläinen, et al.Journal of Clinical Pharmacology|October 15, 2013
Early-stage comparative effectiveness: randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patientsHong Sun, Catherine MacLeod, Kate Mostoller, et al.Brain : a Journal of Neurology|November 30, 2020
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brainCyrille Sur, James Kost, David Scott, et al.Journal of Clinical Pharmacology|February 23, 2010
Single- and multiple-dose pharmacokinetics and tolerability of telcagepant, an oral calcitonin gene-related peptide receptor antagonist, in adultsTae H Han, Rebecca L Blanchard, John Palcza, et al.Biological Psychiatry|December 21, 2014
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical TrialsW Joseph Herring, Kathryn M Connor, Neely Ivgy-May, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 13, 2020
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's diseaseAlette M Wessels, Christopher Lines, Robert A Stern, et al.Pageof 6